Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases

Izzo, 2004, Parotid gland cancer: a case report of a primitive adenocarcinoma arising from a multirecurrent pleomorphic adenoma, J Exp Clin Cancer Res, 23, 153 Olsen, 2001, Carcinoma ex pleomorphic adenoma: a clinicopathologic review, Head Neck, 23, 705, 10.1002/hed.1100 Furukawa, 2001, Carcinoma ex pleomorphic adenoma of the palatal minor salivary gland with extension into the nasopharynx, Auris Nasus Larynx, 28, 279, 10.1016/S0385-8146(01)00052-9 1992 Lewis, 2001, Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases, Hum Pathol, 32, 596, 10.1053/hupa.2001.25000 Sakamoto, 2003, Usefulness of heavily T2 weighted magnetic resonance images for the differential diagnosis of parotid tumours, Dentomaxillofac Radiol, 32, 295, 10.1259/dmfr/32387150 Felix, 1999, Laminin and collagen IV in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: an immunohistochemical study, Hum Pathol, 30, 964, 10.1016/S0046-8177(99)90251-4 Saleh, 2003, Neural adhesion molecule (N-CAM) in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma, J Oral Pathol Med, 32, 562, 10.1034/j.1600-0714.2003.00076.x Haller, 2002, Docetaxel in advanced gastric cancer, Anticancer Drugs, 13, 451, 10.1097/00001813-200206000-00003 Jatoi, 2002, A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia, Int J Gastrointest Cancer, 32, 115, 10.1385/IJGC:32:2-3:115